Association Between Nonmedical Use of Prescription Drugs and Suicidal Behavior Among Adolescents
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: Suicidal behavior is a leading cause of injury and death worldwide, and previous cross-sectional studies have demonstrated that nonmedical use of prescription drugs (NMUPD) was associated with suicidality. However, there is not any study in China having examined the longitudinal relationships between NMUPD, suicidal ideation, and suicidal attempts, as well as explored the potential mediating effects of depressive symptoms. OBJECTIVE: To determine whether baseline NMUPD was associated with subsequent suicidal ideation and attempts while controlling for depressive symptoms and to determine whether the increased risks were mediated by depressive symptoms. DESIGN, SETTING, AND PARTICIPANTS: In this longitudinal study, a total of 3273 students in randomly selected schools in Guangzhou were surveyed from 2009 to 2010 (response rate, 96.8%) and followed up at 1 year (2011-2012; retention rate, 96.1%). The dates of data analysis were October 9, 2015, to October 15, 2015; additional data analysis occurred March 23, 2016, to March 29, 2016. MAIN OUTCOMES AND MEASURES: Suicidal ideation, suicidal attempts, NMUPD, depressive symptoms, and alcohol-related problems. RESULTS: Overall, 3273 adolescents (mean [SD] age, 13.7 [1.0] years) were recruited for this study. The final results showed that after controlling for sociodemographic information (including sex, age, household socioeconomic status, and living arrangements), baseline depressive symptoms, baseline alcohol-related problems, baseline suicidal ideation, and baseline suicidal attempts, baseline opioids misuse (adjusted odds ratio [AOR], 2.31; 95% CI, 1.30-4.11), sedatives misuse (AOR, 4.46; 95% CI, 1.54-7.94), and nonmedical use of any prescription drug (AOR, 1.97; 95% CI, 1.21-3.23) were positively associated with suicidal ideation at follow-up. Additionally, baseline opioid misuse (AOR, 3.39; 95% CI, 1.33-5.63) and nonmedical use of any prescription drug (AOR, 2.91; 95% CI, 1.26-3.71) were also associated with subsequent suicidal attempts after controlling for sex, age, household socioeconomic status, living arrangements, depressive symptoms, alcohol-related problems, suicidal ideation, and suicidal attempts at baseline. There were significant standardized indirect effects of baseline opioids misuse on subsequent suicidal ideation (standardized β estimate = 0.020; 95% CI, 0.010-0.030) and suicidal attempts (standardized β estimate = 0.009; 95% CI, 0.004-0.015) through depressive symptoms; the standardized indirect effect of baseline sedatives misuse on subsequent suicidal ideation through depressive symptoms was also significant (standardized β estimate = 0.016; 95% CI, 0.005-0.026). CONCLUSIONS AND RELEVANCE: In this study, NMUPD at baseline was associated with subsequent suicidal ideation and attempts. These findings support that proper surveillance systems with the potential to reduce adolescent suicidality should be established to control and supervise suicidality and NMUPD among Chinese adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nock, M. K., Borges, G., Bromet, E. J., Cha, C. B., Kessler, R. C., & Lee, S. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn002 · Cited by 2,897
The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults
Radloff, L. S. (1991) · Journal of Youth and Adolescence · doi:10.1007/bf01537606 · Cited by 1,997
Introduction to mediation analysis with structural equation modeling.
(2013) · PubMed Central · doi:10.3969/j.issn.1002-0829.2013.06.009 · Cited by 661
Epidemiology of completed and attempted suicide: toward a framework for prevention
Mościcki, E. K. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00032-9 · Cited by 359
Characteristics of Borderline Personality Disorder Associated With Suicidal Behavior
Brodsky, B. S., Malone, K. M., Ellis, S. P., Dulit, R. A., & Mann, J. J. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1715 · Cited by 297
The Change in Suicide Rates between 2002 and 2011 in China
Zhang, J., Sun, L., Liu, Y., & Zhang, J. (2014) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12090 · Cited by 103
Shimamoto, A., DeBold, J. F., Holly, E. N., & Miczek, K. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2364-7 · Cited by 81
Cited by
The epidemiology of benzodiazepine misuse: A systematic review*
Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.033 · Cited by 479
Guo, L., Luo, M., Wang, W.-X., Huang, G.-L., Xu, Y., Gao, X., Lu, C.-Y., & Zhang, W.-H. (2018) · Journal of Behavioral Addictions · doi:10.1556/2006.7.2018.115 · Cited by 114
Self-citationZuckermann, A. M. E., Qian, W., Battista, K., Jiang, Y., de Groh, M., & Leatherdale, S. T. (2020) · Journal of Substance Use · doi:10.1080/14659891.2020.1736669 · Cited by 15
Nonmedical Use of Controlled Medications by Adolescents and Young Adults: Clinical Report
Chadi, N., Walker-Harding, L., COMMITTEE ON SUBSTANCE USE AND PREVENTION, Gonzalez, L., Camenga, D. R., Engster, S., Quigley, J., Zoucha, K., Walker-Harding, L., Kurten, C., et al. (2024) · Pediatrics · doi:10.1542/peds.2024-069298 · Cited by 9
Metadata
- Authors
- Guo, L., Xu, Y., Deng, J., Huang, J., Huang, G., Gao, X., Wu, H., Pan, S., Zhang, W.-H., & Lu, C.
- Venue
- JAMA Pediatrics
- Publisher
- American Medical Association (AMA)
- Published
- 2016-10-01
- Volume
- 170
- Issue
- 10
- Pages
- 971
- ISSN
- 1072-4710 (ISSN-L)
- 2168-6203
- OpenAlex
- W2513123391
- Cited by
- 80
- References
- 7
- FWCI
- 14.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.